Skip to content

Epiretinal membrane peeling combined with subretinal injection for treatment of macular pucker and severely thick inner retina: prospective randomized controlled clinical trial

Epiretinal membrane peeling combined with subretinal injection for treatment of macular pucker and severely thick inner retina: prospective randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019797
Enrollment
Unknown
Registered
2018-11-29
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular pucker

Interventions

1:Vitrectomy combined with epiretinal membrane peeling, subretinal injection, vitreous cavity filling air
2:Vitrectomy combined with epiretinal membrane peeling, vitreous cavity filling air

Sponsors

Wuhan Aier Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) The patient volunteered for the study and signed informed consent; 2) Aged = 50 years old; 3) The study eye was diagnosed with macular pucker; 4) Baseline BCVA of the study eye = 0.4; 5) Baseline thickness of the fovea inner layer of the study eye = 190 um.

Exclusion criteria

Exclusion criteria: 1) Cornea and lens of the study eye are severely turbid, and the fundus cannot be seen clearly; 2) The study eye with retinal vasculopathy, uveitis, history of ocular trauma, retinal tears and other eye diseases; 3) The study eye has undergone vitreoretinal surgery; 4) The patient has surgical contraindications and the risk of surgery is high.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuity;microperimetry;Optical coherent tomography;

Countries

China

Contacts

Public ContactJianhua Wu

Wuhan Aier Eye Hospital

jhwuwh@vip.163.com+86 13886130515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026